The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer. A systematic review of the literature
暂无分享,去创建一个
[1] S. Ng,et al. NSAID-induced gastrointestinal and cardiovascular injury , 2010, Current opinion in gastroenterology.
[2] S. Kaasa,et al. Content development for EUROPEAN GUIDELINES on the use of opioids for cancer pain: a systematic review and Expert Consensus Study. , 2010, Minerva anestesiologica.
[3] J. L. Dahl,et al. Removal of opioid/acetaminophen combination prescription pain medications: assessing the evidence for hepatotoxicity and consequences of removal of these medications. , 2010, Pain medicine.
[4] M. Charles,et al. Lack of benefit from paracetamol (acetaminophen) for palliative cancer patients requiring high-dose strong opioids: a randomized, double-blind, placebo-controlled, crossover trial. , 2010, Journal of pain and symptom management.
[5] M. A. van de Laar,et al. Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention. , 2010, Seminars in arthritis and rheumatism.
[6] A. Giglio,et al. Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study , 2010, Supportive Care in Cancer.
[7] A. Sonsuz,et al. Effect of intravenous administration of paracetamol on morphine consumption in cancer pain control , 2009, Supportive Care in Cancer.
[8] M. León,et al. Hydrocodone/Acetaminophen and Tramadol Chlorhydrate Combination Tablets for the Management of Chronic Cancer Pain: A Double-blind Comparative Trial , 2008, The Clinical journal of pain.
[9] A. Giglio,et al. Adjunct dipyrone in association with oral morphine for cancer-related pain: the sooner the better , 2007, Supportive Care in Cancer.
[10] J. M. Rodríguez,et al. Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: a 23-day, prospective, double-blind, randomized, parallel-group study. , 2007, Clinical therapeutics.
[11] A. Paradiso,et al. Cobrotoxin-containing analgesic compound to treat chronic moderate to severe cancer pain: results from a randomized, double-blind, cross-over study and from an open-label study. , 2006, Oncology reports.
[12] M. Teixeira,et al. The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it? , 2006, Supportive Care in Cancer.
[13] J. Lau,et al. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. , 2015, The Cochrane database of systematic reviews.
[14] V. Kouloulias,et al. Comparison of transdermal fentanyl with codeine/paracetamol, in combination with radiotherapy, for the management of metastatic bone pain. , 2005, Journal of opioid management.
[15] M. Stockler,et al. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] K. Mystakidou,et al. Radiotherapy plus either transdermal fentanyl or paracetamol and codeine for painful bone metastases: a randomised study of pain relief and quality of life , 2004, Current medical research and opinion.
[17] J. Hedner,et al. Morphine-sparing effect of diclofenac in cancer pain , 1993, European Journal of Clinical Pharmacology.
[18] S. Christensen,et al. Is there an additive analgesic effect of paracetamol at step 3? A double-blind randomized controlled study , 2003, Palliative medicine.
[19] F. Fulfaro,et al. A randomised controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: effects on dose-escalation and a pharmacoeconomic analysis. , 2002, European journal of cancer.
[20] E. Kalso,et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations , 2001, British Journal of Cancer.
[21] E. Zecca,et al. More on the use of nonsteroidal anti-inflammatories in the management of cancer pain. , 2001, Journal of pain and symptom management.
[22] R. Moore,et al. An Evidence-Based Resource for Pain Relief , 1998 .
[23] L. Simon. Nonsteroidal antiinflammatory drugs and their effects. , 1996, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[24] F. Mosteller,et al. Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: a meta-analysis. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] W. Thorpe,et al. The dose-response relationship of controlled-release codeine (Codeine Contin) in chronic cancer pain. , 1994, Journal of pain and symptom management.
[26] Jr Johnson,et al. The efficacy of choline magnesium trisalicylate (CMT) in the management of metastatic bone pain: a pilot study , 1994, Palliative medicine.
[27] A. Caraceni,et al. A validation study of the WHO method for cancer pain relief , 1987, Cancer.
[28] K. Lamborn,et al. Flurbiprofen for the treatment of bone pain in patients with metastatic breast cancer. , 1986, The American journal of medicine.
[29] Earhart Rh,et al. Analgesia with oral narcotics and added ibuprofen in cancer patients. , 1985 .
[30] C. Sorkness,et al. Analgesia with oral narcotics and added ibuprofen in cancer patients. , 1985, Clinical pharmacy.
[31] T. Ferrer-Brechner,et al. Combination therapy with ibuprofen and methadone for chronic cancer pain. , 1984, The American journal of medicine.